Clinical trial

Patient Tolerability Study of GSK163090

NCT00559299

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-11-01

PhasePHASE1

Study timeline

Study start (unknown)2007-11-01Date precision: month

Registry last updated2012-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Depressive Disorder, Majorunresolved

Major Depressive Disorder (MDD)unresolved

Interventions

GSK163090DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

WichitaKansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00559299 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.